Novel vaccine against a range of diseases caused by the Epstein-Barr virus
Start-up “EBViously“ announces first details of its EBV vaccine candidate
12-Apr-2023 -
EBViously, a spin-off from Helmholtz Munich (HMGU), is led by world-leading experts in Epstein-Barr virus biology, genetics, and immunity and was founded to develop a safe and highly effective preventive vaccine against a range of diseases caused by Epstein-Barr virus (EBV), including infectious ...
Epstein-Barr virus
infectious mononucleosis
vaccine development
+1